Article Versions Notes

Rusnak A, Morrison S, Smith E, Hastings V, Anderson K, Aldridge C, Zelenietz S, Reddick K, Regnier S, Alie E, et al. Feasibility Study and Clinical Impact of Incorporating Breast Tissue Density in High-Risk Breast Cancer Screening Assessment. Current Oncology. 2022; 29(11):8742-8750. https://doi.org/10.3390/curroncol29110688

Rusnak, Alison, Shawna Morrison, Erika Smith, Valerie Hastings, Kelly Anderson, Caitlin Aldridge, Sari Zelenietz, Karen Reddick, Sonia Regnier, Ellen Alie, and et al. 2022. "Feasibility Study and Clinical Impact of Incorporating Breast Tissue Density in High-Risk Breast Cancer Screening Assessment" Current Oncology 29, no. 11: 8742-8750. https://doi.org/10.3390/curroncol29110688

Rusnak, A., Morrison, S., Smith, E., Hastings, V., Anderson, K., Aldridge, C., Zelenietz, S., Reddick, K., Regnier, S., Alie, E., Islam, N., Fasih, R., Peddle, S., Cordeiro, E., Tomiak, E., & Seely, J. M. (2022). Feasibility Study and Clinical Impact of Incorporating Breast Tissue Density in High-Risk Breast Cancer Screening Assessment. Current Oncology, 29(11), 8742-8750. https://doi.org/10.3390/curroncol29110688